The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease
about
Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapyTheoretical Approaches to Lentiviral Mediated Neurotrophin Delivery in Potential Treatments of Parkinson's DiseaseEarly intervention of intravenous KB220IV--neuroadaptagen amino-acid therapy (NAAT) improves behavioral outcomes in a residential addiction treatment program: a pilot study.Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.Bone marrow-derived mesenchymal stem cells increase dopamine synthesis in the injured striatum.Treadmill exercise ameliorates symptoms of attention deficit/hyperactivity disorder through reducing Purkinje cell loss and astrocytic reaction in spontaneous hypertensive ratsOral administration of docosahexaenoic acid activates the GDNF-MAPK-CERB pathway in hippocampus of natural aged rat.Oral fish oil restores striatal dopamine release after traumatic brain injury.Omega-3 fatty acid deficiency impairs frontostriatal recruitment following repeated amphetamine treatment in rats: A 7 Tesla in vivo phMRI study.Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model.Impact of the Chronic Omega-3 Fatty Acids Supplementation in Hemiparkinsonism Model Induced by 6-Hydroxydopamine in Rats.
P2860
Q26382049-A63EF1D9-B1F1-4395-BC79-678419F48626Q26746174-914CBD4E-198C-40E4-BC17-3273645AD7EAQ33818454-6942AAE6-372D-4AA3-A631-8770992ECD7DQ34027672-B6849B2C-9F33-4C64-8B4F-2F76853F5250Q34358267-C639223E-EF59-4A3B-A810-6D7D7DAEE9E3Q37635303-7622F9B3-29B5-41A0-B14D-B9FB9F708F12Q39139656-DDC3B7C5-5116-41B1-99C8-C918AD7BA386Q41965524-1FA95628-B362-419A-AFBB-2CB10254F803Q47890984-2A61A820-C1EA-441C-92EA-491995D6F7FCQ48271852-ACA0E60C-0DB4-4E16-AD20-1E533D646C5FQ48418240-75AE6797-A2D3-4204-9258-7C82DBAB825D
P2860
The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease
description
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2010
@ast
im September 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2010/09/30)
@sk
vědecký článek publikovaný v roce 2010
@cs
wetenschappelijk artikel (gepubliceerd op 2010/09/30)
@nl
наукова стаття, опублікована у вересні 2010
@uk
مقالة علمية (نشرت في 30-9-2010)
@ar
name
The effects of docosahexaenoic ...... t model of Parkinson's disease
@ast
The effects of docosahexaenoic ...... t model of Parkinson's disease
@en
The effects of docosahexaenoic ...... t model of Parkinson's disease
@nl
type
label
The effects of docosahexaenoic ...... t model of Parkinson's disease
@ast
The effects of docosahexaenoic ...... t model of Parkinson's disease
@en
The effects of docosahexaenoic ...... t model of Parkinson's disease
@nl
prefLabel
The effects of docosahexaenoic ...... t model of Parkinson's disease
@ast
The effects of docosahexaenoic ...... t model of Parkinson's disease
@en
The effects of docosahexaenoic ...... t model of Parkinson's disease
@nl
P2093
P3181
P1476
The effects of docosahexaenoic ...... t model of Parkinson's disease
@en
P2093
Aysel Agar
Feyza Savcioglu
Gamze Tanriover
Gokhan Akkoyunlu
Gulay Hacioglu
Necdet Demir
Ozlem Ozsoy
P304
P3181
P356
10.2478/V10042-010-0047-6
P577
2010-09-01T00:00:00Z